++
++
Physician, Assistant Professor
++
Radiology & Imaging Sciences
++
National Institutes of Health
++
++
++
++
++
Virginia Cancer Specialists
++
Specialist in Medical Oncology and Hematology
++
++
Leukemia, Acute Lymphoblastic (ADULT); Leukemia, Acute Myeloid
++
++
Carmen Joseph Allegra, MD
++
Professor and Chief Hematology and Oncology
++
++
University of Florida Health
++
++
++
++
++
Professor of Medicine, Department of Medicine,
++
++
Physician, Oncology, Brigham and Women's Hospital
++
Medical Director, Kraft Family Blood Center,
++
Dana-Farber Cancer Institute
++
++
++
++
++
Head, Bladder Cancer Section
++
Genitourinary Malignancies Branch
++
Center for Cancer Research, National Cancer Institute
++
National Institutes of Health
++
++
++
++
++
Member and Professor of Medicine
++
Genitourinary Oncology Service
++
Memorial Sloan-Kettering Cancer Center
++
++
++
++
John R. Bartholomew, MD, FACC, MSVM
++
Professor of Medicine and
++
Section Head of Vascular Medicine
++
Cardiovascular Medicine and Hematology
++
++
++
Heparin-Induced Thrombocytopenia
++
++
++
Medical Director, Southern Iron Disorders Center
++
Clinical Professor of Medicine
++
University of Alabama at Birmingham
++
++
++
++
++
++
Head, Molecular Therapeutics Section
++
++
National Cancer Institute, National Institutes of Health
++
++
++
++
++
Professor of Medicine, Harvard Medical School
++
Director, Thrombosis Clinical Research,
++
Beth Israel Deaconess Medical Center
++
++
The Hypercoagulable State
++
++
++
Chief, Pain and Palliative Care Service
++
National Institutes of Health Clinical Center
++
++
Cancer Pain: Assessment and Management
++
++
++
Department of Medical Oncology
++
Dana Farber Cancer Institute
++
++
++
++
++
++
++
Director, Hematopoietic Stem Cell Transplantation Program
++
The University of Chicago Medicine
++
++
Complications and Follow-Up After Hematopoietic Cell Transplantation
++
++
++
Professor of Medicine in Medical Oncology
++
Head of the Medical Oncology Department
++
Centre Leon Berard of the Université Claude Bernard
++
Scientific Director, Canceropole Lyon Rhône Alpes
++
++
++
++
++
Chair, Department of Medicine, and
++
Member, Memorial Sloan Kettering Cancer Center
++
Professor of Medicine, Weill Cornell Medical College
++
++
++
++
Assistant Professor of Gynecology
++
++
NYU Langone Medical Center
++
++
++
++
Michael M. Boyiadzis, MD, MHSc
++
Associate Professor of Medicine
++
Division of Hematology-Oncology
++
++
University of Pittsburgh School of Medicine
++
University of Pittsburgh Cancer Institute
++
++
Leukemia, Acute Lymphoblastic (ADULT); Leukemia, Acute Myeloid; Complications and Follow-Up After Hematopoietic Cell Transplantation; Aplastic Anemia; Myelodysplastic Syndromes
++
++
Kathleen A. Calzone, PhD, RN, APNG, FAAN
++
Senior Nurse Specialist, Research
++
National Cancer Institute
++
Center for Cancer Research, Genetics Branch
++
++
Cancer Screening; Genetics of Common Inherited Cancer Syndromes
++
++
++
Assistant Professor of Medicine
++
University of Rochester Medical Center at Strong Memorial Hospital
++
++
++
++
++
Assistant Professor, University of Florida
++
Section Chief, Hematology/Oncology,
++
Gainesville VA Medical Center
++
++
++
++
Jennifer Cuellar-Rodriguez, MD
++
++
Laboratory of Clinical Infectious Diseases
++
National Institute of Allergy and Infectious Diseases
++
++
++
++
++
++
++
Genitourinary Malignancies Branch
++
Center for Cancer Research
++
National Cancer Institute, National Institutes of Health
++
++
++
++
++
Director, University of Pittsburgh Cancer Institute
++
++
Associate Vice Chancellor for Cancer Research
++
Professor of Medicine, University of Pittsburgh
++
++
++
++
Michael W.N. Deininger, MD, PhD
++
Chief, Division of Hematology and Hematologic Malignancies
++
M.M. Wintrobe Professor of Medicine
++
++
Huntsman Cancer Institute
++
++
Leukemia, Chronic Myelogenous
++
++
++
Associate Professor of Medicine
++
Beth Israel Deaconess Medical Center
++
++
++
++
++
++
Emeritus Professor of Medicine, Hematology, Oncology
++
++
++
++
++
++
Director, Oregon Health & Science University Knight Cancer Institute
++
JELD-WEN Chair of Leukemia Research
++
Investigator, Howard Hughes Medical Institute
++
++
Leukemia, Chronic Myelogenous
++
++
++
First Department of Internal Medicine and German
++
++
University Hospital Cologne
++
++
++
++
++
Uppsala University Hospital
++
++
Pancreatic Endocrine Tumors
++
++
Jennifer Eng-Wong, MD, MPH
++
Assistant Medical Director
++
++
South San Francisco, California
++
++
++
Jonas W. Feilchenfeldt, MD
++
++
FMH Internal Medicine and Medical Oncology
++
Department of Medical Oncology
++
++
++
++
++
++
Assistant Member, Department of Medicine
++
Memorial Sloan Kettering Cancer Center, and
++
Assistant Professor in Medicine, Weill Cornell Medical College
++
++
++
++
++
Department of Medical Oncology
++
Vall d'Hebron University Hospital
++
++
++
++
++
Director, Division of Hematology and Oncology
++
Director, NYU Brain Tumor Center
++
Deputy Director, NYU Cancer Institute
++
Director, Bellevue Hospital Cancer Center
++
The New York University (NYU) Langone Medical Center
++
++
++
++
++
++
++
Fox Chase Cancer Center - Temple Health
++
++
Temple University School of Medicine
++
Philadelphia, Pennsylvania
++
++
++
++
++
++
Center for Cancer Research
++
National Cancer Institute
++
National Institutes of Health
++
++
Adrenocortical Cancer; Pheochromocytoma; Sarcomas; Guidelines for Chemotherapy Dosage Adjustment; Oncologic Emergencies
++
++
++
Vice President, Global Medical Affairs, Lymphoma and CLL
++
++
++
++
Leukemia, Chronic Lymphocytic
++
++
++
Clinical Professor of Medicine
++
Robert C. Byrd Health Sciences Center
++
West Virginia University School of Medicine
++
Medical Director, David Lee Cancer Center
++
Charleston Area Medical Center Health Systems
++
Charleston, West Virginia
++
Indications for Growth Factors in Hematology-Oncology;
++
Indications for Bone-Modifying Agents in Hematology-Oncology;
++
Heparin-Induced Thrombocytopenia; Autoimmune Hemolytic Anemia;
++
Sickle Cell Disease: Acute Complications
++
++
Jonathan W. Friedberg, MD, MMSc
++
Director, James P. Wilmot Cancer Center
++
Samuel Durand Professor of Medicine and Oncology
++
++
++
++
++
++
Head of the Trial Coordination Center German Hodgkin Study Group
++
Department of Internal Medicine
++
University Hospital of Cologne
++
++
++
++
++
Assistant Professor of Medicine
++
++
++
++
Myeloproliferative Neoplasms
++
++
Juan C. Gea-Banacloche, MD
++
Chief, Infectious Diseases Consultation Service
++
Experimental Transplantation and Immunology Branch
++
National Cancer Institute, National Institute of Health
++
++
Fever and Neutropenia; Complications and Follow-Up After Hematopoietic Cell Transplantation
++
++
++
George Lynn Cross Professor
++
Departments of Medicine, Biostatistics & Epidemiology
++
University of Oklahoma Health Sciences Center
++
++
Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome; Idiopathic Thrombocytopenic Purpura
++
++
++
Associate Professor of Medicine
++
Dana-Farber Cancer Institute
++
++
++
++
++
Giuseppe Giaccone, MD, PhD
++
Associate Director for Clinical Research
++
Georgetown Lombardi Comprehensive Cancer Center
++
Director of Clinical Research, MedStar Georgetown Health Cancer
++
Network's Washington Region
++
Georgetown University Medical Center
++
++
++
++
Amanda L. Gillespie-Twardy, MD
++
University of Pittsburgh School of Medicine
++
++
++
++
++
Professor, Department of Radiation Oncology
++
University of Pennsylvania
++
Philadelphia, Pennsylvania
++
++
++
++
++
Center for Cancer Research
++
National Cancer Institute, NIH
++
++
++
++
++
Clinical Researcher and Director
++
Sarah Cannon Research Institute
++
++
Carcinoma of Unknown Primary
++
++
++
++
Gastrointestinal Malignancy Section
++
Center for Cancer Research
++
National Cancer Institute
++
++
Biliary: Gallbladder Cancer and Cholangiocarcinoma; Hepatocellular Carcinoma
++
++
Thomas E. Hughes, PharmD, BCOP
++
Oncology Clinical Pharmacy Specialist
++
++
National Institutes of Health Clinical Center
++
++
Prophylaxis and Treatment of Chemotherapy-Induced Nausea and Vomiting
++
++
++
Chief, GI Medical Oncology
++
++
Carolinas Healthcare System
++
Charlotte, North Carolina
++
++
++
++
Assistant Professor of Medicine
++
University of Pittsburgh Cancer Institute
++
UPMC Magee Women's Cancer Program
++
++
++
++
++
Medical Oncologist/Pain Medicine/Hospice & Palliative Care
++
Lawrence Memorial Hospital Oncology Center
++
++
++
++
Steven J. Jubelilirer, MD
++
Clinical Professor of Medicine
++
West Virginia University-Charleston
++
Division Director, CAMC Hemophilia Treatment Center
++
Charleston Area Medical Center
++
Charleston, West Virginia
++
++
++
++
Professor of Oncology and Medicine
++
John Hopkins University School of Medicine
++
++
Leukemia, Acute Lymphoblastic (ADULT); Leukemia, Acute Myeloid
++
++
++
Division of Neuro-Oncology
++
Department of Neurological Surgery
++
Department of Medical Oncology
++
Thomas Jefferson University Hospital
++
Philadelphia, Pennsylvania
++
++
++
++
Usher Professor of Medicine, Dermatology and Translational Science
++
Co-Director, Melanoma and Skin Cancer Program
++
University of Pittsburgh Cancer Institute
++
++
++
++
++
Associate Professor of Medicine
++
++
Division of Hematology/Oncology
++
Medical Director, Hemapheresis and Blood Services
++
++
++
++
++
++
Oncology Clinical Pharmacy Specialist
++
++
Drug Preparation and Administration;
++
Antineoplastic Drugs: Preventing and Managing Extravasation
++
++
++
Skagit Valley Hospital Regional Cancer Care Center
++
Seattle Cancer Care Alliance
++
++
Skagit Valley Hospital Regional Cancer Care Clinic
++
++
Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome;
++
Idiopathic Thrombocytopenic Purpura
++
++
++
Assistant Professor of Medicine
++
++
++
Philadelphia, Pennsylvania
++
Leukemia, Chronic Lymphocytic
++
++
Peter F. Lebowitz, MD, PhD
++
Global Head of Oncology Research and Development
++
Janssen, Pharmaceutical Companies of Johnson & Johnson
++
Spring House, Pennsylvania
++
++
++
++
Marcia Stenn Professor of Gynecologic Oncology
++
Gynecologic Oncology Fellowship Program Director
++
Northwestern University, Feinberg School of Medicine
++
++
Gestational Trophoblastic Neoplasia
++
++
++
++
++
IRCCS Ca'Granda Maggiore Policlinico Hospital Foundation
++
++
++
++
++
Senior Vice President for Clinical Affairs
++
Cancer Treatment Centers of America
++
Clinical Professor of Medicine
++
Drexel University of College of Medicine
++
Philadelphia, Pennsylvania
++
++
++
++
Director, The Ruesch Center for the Cure of GI Cancers
++
Chief, Hematology and Oncology
++
Lombardi Comprehensive Cancer Center
++
Georgetown University Medical Center
++
++
Anal Cancer; Esophageal Cancer
++
++
Pamela W. McDevitt, PharmD, BCOP
++
Oncology Clinical Pharmacy Specialist
++
++
Charleston, West Virginia
++
Guidelines for Chemotherapy Dosage Adjustment; Indications for Growth Factors in Hematology-Oncology
++
++
++
Professor of Medicine (Oncology)
++
++
NYU Langone Medical Center
++
++
++
++
++
Health Science Associate Clinical Professor
++
Department of Laboratory Medicine
++
Director, Transfusion Medicine
++
Director, Moffitt-Long & Mt. Zion Hospital Tissue Banks
++
++
University of California, San Francisco
++
San Francisco, California
++
++
++
++
Medical Director, Procedures, Vascular Access,
++
and Conscious Sedation Services
++
Department of Critical Care Medicine
++
National Institutes of Health
++
++
Catheter-Related Bloodstream Infections: Management and Prevention
++
++
Karel Pacak, MD, PhD, DSc
++
++
Chief, Section on Medical Neuroendocrinology
++
Eunice Kennedy Shriver NICHD, National Institutes of Health
++
++
++
++
Mauricio Burotto Pichun, MD
++
++
Center for Cancer Research
++
National Cancer Institute, National Institutes of Health
++
++
++
++
Sheila Prindiville, MD, MPH
++
Director, Coordinating Center for Clinical Trials
++
National Cancer Institute
++
++
Cancer Screening; Genetics of Common Inherited Cancer Syndromes
++
++
++
Professor of Medicine and Clinical Translational Science
++
++
Division of Hematology-Oncology
++
++
Director, Hemophilia Center of Western Pennsylvania
++
++
++
++
++
++
Center for Cancer Research
++
National Cancer Institute, National Institutes of Health
++
++
++
++
Ramesh K. Ramanathan, MD, PhD, Sc
++
Virginia G. Piper Cancer Center - Clinical Trials
++
++
++
Clinical Professor of Medicine, Translational Genomics Research
++
Institute and College of Medicine
++
++
++
++
++
++
++
National Institute on Minority Health and Health Disparities
++
National Institutes of Health
++
++
++
++
++
++
Associate Member, Fred Hutchinson Cancer Research Center
++
Medical Director, SCCA Proton Therapy
++
Department of Radiation Oncology
++
++
++
++
++
++
Director, Experimental Therapeutics Program
++
Leader, Neuro-Oncology Program
++
Georgia Regents University Cancer Center
++
++
++
++
++
Dana Farber Cancer Institute
++
++
++
++
++
Griffin P. Rodgers, MD, MACP
++
Chief, Molecular and Clinical Hematology Branch
++
National Heart, Lung and Blood Institute
++
Director, National Institute of Diabetes,
++
Digestive and Kidney Diseases
++
National Institutes of Health
++
++
Sickle Cell Disease: Acute Complications
++
++
++
Section Head Gynecologic Oncology
++
Cleveland Clinic Foundation
++
Tenured Professor of Surgery, Oncology and Reproductive Biology
++
Case Western Reserve University
++
++
++
++
++
Director, Cancer Biology and Precision Medicine Program
++
Catalan Institute of Oncology,
++
Hospital Germans Trias i Pujol, Badalona
++
Pangaea Biotech, Quirón-Dexeus University Hospital
++
++
++
++
Julia Schaefer-Cutillo, MD
++
++
Hudson Valley Hematology Oncology
++
++
++
++
++
++
Department of Internal Medicine I
++
++
Vienna University Medical School, Vienna University Hospital
++
++
Biliary: Gallbladder Cancer and Cholangiocarcinoma
++
++
Lee S. Schwartzberg, MD, FACP
++
Chief, Division of Hematology Oncology
++
++
The University of Tennessee Health Science Center
++
++
Indications for Growth Factors in Hematology-Oncology
++
++
++
++
Genitourinary Malignancies Branch
++
Center for Cancer Research
++
National Cancer Institute, National Institutes of Health
++
++
++
++
++
Associate Professor of Medicine
++
Director, Gastrointestinal Oncology
++
Weill Cornell Medical College of Cornell University
++
++
++
++
++
Reem Abozena Shalabi, PharmD, BCOP
++
Clinical Pharmacy Specialist
++
Blood and Marrow Transplantation
++
National Institutes of Health
++
++
Indications for Bone-Modifying Agents in Hematology-Oncology
++
++
++
Professor of Endocrine Tumorbiology
++
Department of Endocrine Oncology
++
Uppsala University Hospital
++
++
Pancreatic Endocrine Tumors
++
++
++
++
Division of Hematology/Oncology
++
University of Pittsburgh Cancer Institute
++
++
Venous Catheter-Related Thrombosis
++
++
++
Antwerp University Hospital
++
++
++
++
++
Director, Lung Cancer Research Program
++
Sarah Cannon Research Institute
++
++
Carcinoma of Unknown Primary
++
++
++
++
Department of Radiation Oncology
++
University of Pennsylvania
++
Hospital of University of Pennsylvania
++
Philadelphia, Pennsylvania
++
++
++
++
Chief of the Leukemia Service
++
++
Memorial Sloan Kettering Cancer Center
++
++
Weill Cornell Medical College
++
++
++
++
Ahmad A. Tarhini, MD, PhD
++
Associate Professor of Medicine, Clinical and Translational Science
++
++
Division of Hematology/Oncology
++
++
++
++
++
++
++
++
++
++
Myeloproliferative Neoplasms
++
++
++
Associate Professor of Clinical Medicine
++
NK Basile Cancer Institute
++
American University of Beirut Medical Center
++
++
Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome; Idiopathic Thrombocytopenic Purpura
++
++
++
Thoracic and Gastrointestinal Oncology Branch
++
National Cancer Institute, National Institutes of Health
++
++
++
++
++
Center for Cancer Research
++
National Cancer Institute, National Institutes of Health
++
++
Biliary: Gallbladder Cancer and Cholangiocarcinoma
++
++
++
++
National Centre of Radiotherapy and Nuclear Medicine
++
Korle Bu Teaching Hospital
++
++
++
++
++
Emeritus Professor of Oncology
++
Department of Medical Oncology
++
Antwerp University Hospital
++
++
++
++
Daniel D. Von Hoff, MD, FACP
++
Physician in Chief, Distinguished Professor
++
Translational Genomics Research Institute
++
Professor of Medicine, Mayo Clinic
++
Chief Scientific Officer, Scottsdale Healthcare
++
Medical Director of Research and Scientific Medical Officer,
++
++
++
Clinical Professor of Medicine
++
Translational Genomics Research Institute
++
University of Arizona Cancer Center
++
++
++
++
Nicholas J. Vogelzang, MD
++
++
++
Comprehensive Cancer Centers of Nevada
++
++
++
++
Charles F. von Gunten, MD, PhD
++
Vice President, Medical Affairs
++
Hospice and Palliative Medicine for OhioHealth
++
++
Hospice Care and End-of-Life Issues
++
++
++
Director of the Palliative Care Center
++
++
Division of Hematology and Oncology
++
Medical College of Wisconsin
++
++
Hospice Care and End-of-Life Issues
++
++
++
Center for Cancer Research
++
National Cancer Institute, National Institutes of Health
++
++
++
++
++
++
Pediatric Oncology Branch
++
Center for Cancer research
++
National Cancer Institute, National Institutes of Health
++
++
++
++
++
++
National Heart, Lung, and Blood Institute,
++
National Institutes of Health
++
++
Aplastic Anemia; Myelodysplastic Syndromes
++
++
++
++
Southwest General Hospital
++
++
++
++
++
Assistant Professor of Medicine
++
Division of Hematology-Oncology
++
Beth Israel Deaconess Medical Center, Harvard Medical School
++
++
The Hypercoagulable State